269 related articles for article (PubMed ID: 15668468)
21. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma.
Kuo SH; Weng WH; Chen ZH; Hsu PN; Wu MS; Lin CW; Jeng HJ; Yeh KH; Tsai HJ; Chen LT; Cheng AL
Genes Chromosomes Cancer; 2011 Nov; 50(11):908-21. PubMed ID: 21837708
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma.
Wöhrer S; Streubel B; Bartsch R; Chott A; Raderer M
Clin Cancer Res; 2004 Nov; 10(21):7179-81. PubMed ID: 15534090
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal imbalances are associated with outcome of Helicobacter pylori eradication in t(11;18)(q21;q21) negative gastric mucosa-associated lymphoid tissue lymphomas.
Fukuhara N; Nakamura T; Nakagawa M; Tagawa H; Takeuchi I; Yatabe Y; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2007 Aug; 46(8):784-90. PubMed ID: 17492756
[TBL] [Abstract][Full Text] [Related]
25. A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma.
Khan KD; Emmanouilides C; Benson DM; Hurst D; Garcia P; Michelson G; Milan S; Ferketich AK; Piro L; Leonard JP; Porcu P; Eisenbeis CF; Banks AL; Chen L; Byrd JC; Caligiuri MA
Clin Cancer Res; 2006 Dec; 12(23):7046-53. PubMed ID: 17145827
[TBL] [Abstract][Full Text] [Related]
26. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
[TBL] [Abstract][Full Text] [Related]
27. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Aydin S; Dührsen U; Nückel H
Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
[TBL] [Abstract][Full Text] [Related]
28. Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma.
Rothe A; Schulz H; Elter T; Engert A; Reiser M
Haematologica; 2004 Jul; 89(7):875-6. PubMed ID: 15257947
[TBL] [Abstract][Full Text] [Related]
29. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
Delchier JC
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):453-8. PubMed ID: 12700502
[TBL] [Abstract][Full Text] [Related]
30. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Group.
Witzig TE; Vukov AM; Habermann TM; Geyer S; Kurtin PJ; Friedenberg WR; White WL; Chalchal HI; Flynn PJ; Fitch TR; Welker DA
J Clin Oncol; 2005 Feb; 23(6):1103-8. PubMed ID: 15657404
[TBL] [Abstract][Full Text] [Related]
31. Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
Friedberg JW; Cohen P; Chen L; Robinson KS; Forero-Torres A; La Casce AS; Fayad LE; Bessudo A; Camacho ES; Williams ME; van der Jagt RH; Oliver JW; Cheson BD
J Clin Oncol; 2008 Jan; 26(2):204-10. PubMed ID: 18182663
[TBL] [Abstract][Full Text] [Related]
32. Our experience in Helicobacter pylori infection and gastric MALToma.
Losacco T; Cagiano R; Bottalico L; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Santacroce L
Clin Ter; 2008; 159(4):239-42. PubMed ID: 18776980
[TBL] [Abstract][Full Text] [Related]
33. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
34. Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study.
Radman I; Kovacević-Metelko J; Aurer I; Nemet D; Zupancić-Salek S; Bogdanić V; Sertić D; Mrsić M; Pulanić R; Gasparović V; Labar B
Croat Med J; 2002 Oct; 43(5):555-60. PubMed ID: 12402395
[TBL] [Abstract][Full Text] [Related]
35. Combined histology and molecular biology for diagnosis of early stage gastric MALT lymphoma.
Yi ZH; Ouyang Q; Li GD; Chen DY
Chin J Dig Dis; 2006; 7(1):12-8. PubMed ID: 16412032
[TBL] [Abstract][Full Text] [Related]
36. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
[TBL] [Abstract][Full Text] [Related]
37. Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.
Desar IM; Keuter M; Raemaekers JM; Jansen JB; van Krieken JH; van der Meer JW
Neth J Med; 2006 May; 64(5):136-40. PubMed ID: 16702611
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.
Grünberger B; Wöhrer S; Streubel B; Formanek M; Petkov V; Puespoek A; Haefner M; Hejna M; Jaeger U; Chott A; Raderer M
J Clin Oncol; 2006 Mar; 24(9):1370-5. PubMed ID: 16549831
[TBL] [Abstract][Full Text] [Related]
40. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications.
Ferreri AJ; Ponzoni M; Viale E; Guidoboni M; Conciliis CD; Resti AG; Politi L; Lettini AA; Sacchetti F; Dognini G; Dolcetti R; Doglioni C
Hematol Oncol; 2006 Mar; 24(1):33-7. PubMed ID: 16385613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
